Literature DB >> 15451059

A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties.

Sameh S Ali1, Joshua I Hardt, Kevin L Quick, Jeong Sook Kim-Han, Bernard F Erlanger, Ting-Ting Huang, Charles J Epstein, Laura L Dugan.   

Abstract

Superoxide, a potentially toxic by-product of cellular metabolism, may contribute to tissue injury in many types of human disease. Here we show that a tris-malonic acid derivative of the fullerene C60 molecule (C3) is capable of removing the biologically important superoxide radical with a rate constant (k(C3)) of 2 x 10(6) mol(-1) s(-1), approximately 100-fold slower than the superoxide dismutases (SOD), a family of enzymes responsible for endogenous dismutation of superoxide. This rate constant is within the range of values reported for several manganese-containing SOD mimetic compounds. The reaction between C3 and superoxide was not via stoichiometric "scavenging," as expected, but through catalytic dismutation of superoxide, indicated by lack of structural modifications to C3, regeneration of oxygen, production of hydrogen peroxide, and absence of EPR-active (paramagnetic) products, all consistent with a catalytic mechanism. A model is proposed in which electron-deficient regions on the C60 sphere work in concert with malonyl groups attached to C3 to electrostatically guide and stabilize superoxide, promoting dismutation. We also found that C3 treatment of Sod2(-/-) mice, which lack expression of mitochondrial manganese superoxide dismutase (MnSOD), increased their life span by 300%. These data, coupled with evidence that C3 localizes to mitochondria, suggest that C3 functionally replaces MnSOD, acting as a biologically effective SOD mimetic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15451059     DOI: 10.1016/j.freeradbiomed.2004.07.002

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  43 in total

1.  Distinct Impacts of Fullerene on Cognitive Functions of Dementia vs. Non-dementia Mice.

Authors:  Yawen Wu; Runzi Wang; Yuexiang Wang; Jing Gao; Lina Feng; Zhuo Yang
Journal:  Neurotox Res       Date:  2019-06-20       Impact factor: 3.911

2.  Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly(2-oxazoline)s nanoformulation.

Authors:  Jing Tong; Matthew C Zimmerman; Shumin Li; Xiang Yi; Robert Luxenhofer; Rainer Jordan; Alexander V Kabanov
Journal:  Biomaterials       Date:  2011-02-20       Impact factor: 12.479

3.  Synthesis and properties of novel water-soluble fullerene-glycine derivatives as new materials for cancer therapy.

Authors:  Guichang Jiang; Fen Yin; Jihua Duan; Guangtao Li
Journal:  J Mater Sci Mater Med       Date:  2015-01-13       Impact factor: 3.896

4.  Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates.

Authors:  Laura L Dugan; LinLin Tian; Kevin L Quick; Josh I Hardt; Morvarid Karimi; Chris Brown; Susan Loftin; Hugh Flores; Stephen M Moerlein; John Polich; Samer D Tabbal; Jonathan W Mink; Joel S Perlmutter
Journal:  Ann Neurol       Date:  2014-07-22       Impact factor: 10.422

Review 5.  Chemical basis of interactions between engineered nanoparticles and biological systems.

Authors:  Qingxin Mu; Guibin Jiang; Lingxin Chen; Hongyu Zhou; Denis Fourches; Alexander Tropsha; Bing Yan
Journal:  Chem Rev       Date:  2014-06-13       Impact factor: 60.622

6.  Pharmacokinetics and Toxicology of the Neuroprotective e,e,e-Methanofullerene(60)-63-tris Malonic Acid [C3] in Mice and Primates.

Authors:  Joshua I Hardt; Joel S Perlmutter; Christopher J Smith; Kevin L Quick; Ling Wei; Subhasish K Chakraborty; Laura L Dugan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-10       Impact factor: 2.441

7.  Trimetallic Nitride Endohedral Fullerenes Carboxyl-Gd3N@C80: A New Theranostic Agent for Combating Oxidative Stress and Resolving Inflammation.

Authors:  Tinghui Li; Li Xiao; Jiezuan Yang; Mengmeng Ding; Zhiguo Zhou; Leslie LaConte; Li Jin; Harry C Dorn; Xudong Li
Journal:  ACS Appl Mater Interfaces       Date:  2017-05-19       Impact factor: 9.229

Review 8.  Review: Mitochondria and disease progression in multiple sclerosis.

Authors:  D Mahad; H Lassmann; D Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12       Impact factor: 8.090

9.  Zebrafish as a model system to screen radiation modifiers.

Authors:  Misun Hwang; Cha Yong; Luigi Moretti; Bo Lu
Journal:  Curr Genomics       Date:  2007-09       Impact factor: 2.236

10.  SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy.

Authors:  Andrea M Vincent; James W Russell; Kelli A Sullivan; Carey Backus; John M Hayes; Lisa L McLean; Eva L Feldman
Journal:  Exp Neurol       Date:  2007-08-03       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.